New York A10820 mandates managed care providers and the medical assistance program to cover FDA-approved prescription drugs for chronic weight.
New York A10820 amends the social services law to require managed care providers and the medical assistance program to cover FDA-approved prescription drugs for chronic weight management in adults with obesity and at least one weight-related condition. This law aims to expand access to necessary medications for managing chronic weight in eligible adults.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.